Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Lyle

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ductus Arteriosus, Patent
2
2019
38
0.310
Why?
DNA
1
2010
535
0.270
Why?
Asthma
1
2010
284
0.260
Why?
Intensive Care Units, Neonatal
2
2018
124
0.260
Why?
Infant, Premature
4
2019
317
0.210
Why?
Medicaid
2
2018
252
0.200
Why?
Disabled Children
2
2013
62
0.190
Why?
Infant, Newborn
7
2019
2749
0.170
Why?
Hospitalization
2
2017
675
0.160
Why?
Persistent Fetal Circulation Syndrome
1
2019
9
0.160
Why?
Chronic Disease
3
2011
573
0.160
Why?
Health Care Costs
2
2018
167
0.160
Why?
Child, Preschool
7
2018
3942
0.150
Why?
Infant, Low Birth Weight
1
2018
74
0.150
Why?
Continuity of Patient Care
1
2018
52
0.140
Why?
Clinical Protocols
1
2017
110
0.130
Why?
Immunologic Deficiency Syndromes
1
2016
19
0.130
Why?
Hypoglycemia
1
2016
55
0.130
Why?
Infant, Premature, Diseases
1
2017
93
0.130
Why?
DNA Copy Number Variations
2
2016
109
0.130
Why?
Child
8
2018
6906
0.120
Why?
Developmental Disabilities
1
2016
120
0.120
Why?
Hospitals, Pediatric
3
2013
235
0.120
Why?
Emergency Service, Hospital
1
2018
484
0.110
Why?
Comprehensive Health Care
1
2013
9
0.110
Why?
Infant
6
2018
3628
0.100
Why?
Blood Cells
1
2012
47
0.100
Why?
Genome, Human
1
2012
109
0.090
Why?
Child, Exceptional
1
2011
5
0.090
Why?
Cost Savings
1
2011
57
0.090
Why?
Parents
1
2013
318
0.080
Why?
Follow-Up Studies
2
2018
2242
0.080
Why?
Fetal Blood
1
2010
66
0.080
Why?
Gene Expression Regulation, Developmental
1
2010
134
0.080
Why?
Genetic Association Studies
1
2010
119
0.080
Why?
Longitudinal Studies
3
2018
735
0.080
Why?
Ambulatory Care
1
2011
230
0.080
Why?
Patient Care Team
1
2011
258
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2013
491
0.080
Why?
Time Factors
2
2018
2935
0.080
Why?
Humans
13
2022
50503
0.080
Why?
Outpatient Clinics, Hospital
1
2009
36
0.080
Why?
Genotype
1
2010
533
0.080
Why?
Child Health Services
1
2009
78
0.070
Why?
Home Care Services
1
2009
73
0.070
Why?
Female
8
2018
27081
0.070
Why?
Polymorphism, Single Nucleotide
1
2010
475
0.070
Why?
Male
7
2018
25907
0.070
Why?
DNA Methylation
1
2010
550
0.060
Why?
Cohort Studies
3
2018
1452
0.060
Why?
Patient Discharge
2
2018
321
0.060
Why?
Prospective Studies
1
2010
2378
0.060
Why?
Cell Differentiation
2
2022
640
0.050
Why?
Embryonic Stem Cells
1
2022
15
0.050
Why?
Age Factors
2
2018
1110
0.050
Why?
Adolescent
3
2018
6443
0.050
Why?
Acetylcysteine
1
2002
101
0.050
Why?
Peptide Hydrolases
1
2002
61
0.050
Why?
Phosphoproteins
1
2002
115
0.050
Why?
Proteasome Endopeptidase Complex
1
2002
116
0.050
Why?
Arkansas
3
2013
1985
0.050
Why?
Adipocytes
1
2002
126
0.050
Why?
Cell Survival
1
2022
589
0.040
Why?
Neurons
1
2022
452
0.040
Why?
Proteins
1
2002
339
0.040
Why?
Time
1
2018
28
0.040
Why?
Ibuprofen
1
2018
20
0.040
Why?
Indomethacin
1
2018
38
0.040
Why?
United States
3
2018
4955
0.040
Why?
Birth Weight
1
2019
106
0.040
Why?
Cyclooxygenase Inhibitors
1
2018
38
0.040
Why?
Infant, Newborn, Diseases
1
2016
56
0.030
Why?
Patient Readmission
1
2018
227
0.030
Why?
Incidence
1
2018
1032
0.030
Why?
Logistic Models
1
2018
900
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
169
0.030
Why?
Databases, Factual
1
2018
673
0.030
Why?
Length of Stay
1
2018
629
0.030
Why?
Young Adult
2
2016
4102
0.030
Why?
Genomics
1
2016
279
0.030
Why?
Blood Glucose
1
2016
446
0.030
Why?
Risk Assessment
1
2018
1270
0.030
Why?
Health Care Surveys
1
2013
175
0.030
Why?
Twins, Monozygotic
1
2012
15
0.020
Why?
Individuality
1
2012
30
0.020
Why?
Patient-Centered Care
1
2013
130
0.020
Why?
Myelodysplastic Syndromes
1
2012
78
0.020
Why?
Aged
2
2016
9741
0.020
Why?
Cerebral Palsy
1
2010
38
0.020
Why?
Cost-Benefit Analysis
1
2011
266
0.020
Why?
Bronchopulmonary Dysplasia
1
2010
70
0.020
Why?
Multivariate Analysis
1
2011
583
0.020
Why?
Middle Aged
2
2016
12611
0.020
Why?
Adult
2
2016
13577
0.020
Why?
Quality of Life
1
2013
851
0.020
Why?
Program Evaluation
1
2009
349
0.020
Why?
Rural Population
1
2011
554
0.020
Why?
Mutation
1
2012
1280
0.020
Why?
Retrospective Studies
1
2018
6263
0.020
Why?
Aged, 80 and over
1
2012
3226
0.010
Why?
Treatment Outcome
1
2013
5283
0.010
Why?
Leupeptins
1
2002
7
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
22
0.010
Why?
Calpain
1
2002
25
0.010
Why?
Kinetics
1
2002
623
0.010
Why?
Nuclear Proteins
1
2002
238
0.010
Why?
Cell Line
1
2002
988
0.010
Why?
Animals
1
2002
13124
0.000
Why?
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description